Home Compare IONS vs RKLB
Stock Comparison · Single-driver result

Ionis Pharmaceuticals vs Rocket Lab: Which Stock Looks Stronger in 2026?

The structural profiles are close, with Ionis Pharmaceuticals carrying a narrow edge on growth. Rocket Lab still has the edge on growth, which keeps the comparison from looking entirely one-sided. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

Growth points more clearly toward Rocket Lab Corporation, even if the broader score still leans toward Ionis Pharmaceuticals, Inc..

Trajectory Similarity
0.63
Moderately similar
Peer-set rank: #9
within Ionis Pharmaceuticals, Inc.'s functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.

The strongest overlap appears in capital structure and margin consistency.

Similarity drivers
capital structuremargin consistency
What reduces the match
revenue growth trajectory
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
IONS
Ionis Pharmaceuticals, Inc.
27
Peer-Score
Signal qualityHigh
vs
RKLB
Rocket Lab Corporation
25
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in growth.

Dimension spread: IONS vs RKLB Profitability 17 0 Stability 48 31 Valuation 30 8 Growth 18 83 IONS RKLB
Gap Ranking
#1 Growth +65
#2 Valuation +22
#3 Profitability +17
#4 Stability +17
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for IONS and RKLB Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer IONSRKLB Relative valuation Structural strength

The price setup looks more supportive for Rocket Lab Corporation, but Ionis Pharmaceuticals, Inc. still has the stronger structure.

Valuation position uses peer-relative valuation score where available.

Relative Position vs Comparable Companies
Growth
Rocket Lab Corporation ranks near the top of the group on growth; Ionis Pharmaceuticals, Inc. sits in the weaker half.
Valuation
Neither side looks especially strong on valuation, though Ionis Pharmaceuticals, Inc. still ranks somewhat higher.
Growth — Dominant Gap
IONS
18
RKLB
83
Gap+65in favour of RKLB

The main growth separation is very wide, driven by a meaningfully stronger expansion profile.

What else supports the lead

Ionis Pharmaceuticals, Inc. also looks less cycle-sensitive, which gives the profile a calmer footing than a pure score split would imply.

What this means for the comparison

Growth is the clearest driver of the lead, with valuation adding further support — though growth still provides a real counterweight.

Explore full peer positioning in AssetNext

Break down the IONS vs RKLB comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how IONS and RKLB each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.